| Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells A Kanerva, GV Mikheeva, V Krasnykh, CJ Coolidge, JT Lam, ... Clinical Cancer Research 8 (1), 275-280, 2002 | 326 | 2002 |
| Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents GJ Bauerschmitz, SD Barker, A Hemminki International journal of oncology 21 (6), 1161-1174, 2002 | 163 | 2002 |
| Transcriptional targeting of tumors with a novel tumor-specific survivin promoter ZB Zhu, SK Makhija, B Lu, M Wang, L Kaliberova, B Liu, AA Rivera, ... Cancer gene therapy 11 (4), 256-262, 2004 | 147 | 2004 |
| The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy SD Barker, CJ Coolidge, A Kanerva, T Hakkarainen, M Yamamoto, B Liu, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2003 | 91 | 2003 |
| Viral-based modelling and correction of neurodegenerative diseases by RNA interference C Raoul, SD Barker, P Aebischer Gene therapy 13 (6), 487-495, 2006 | 87 | 2006 |
| Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications E Casado, J Gomez-Navarro, M Yamamoto, Y Adachi, CJ Coolidge, ... Clinical cancer research 7 (8), 2496-2504, 2001 | 78 | 2001 |
| Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study. S O'Reilly, GF Fleming, SD Barker, JR Walczak, MA Bookman, ... Journal of clinical oncology 15 (1), 177-186, 1997 | 78 | 1997 |
| Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma SD Barker, IP Dmitriev, DM Nettelbeck, B Liu, AA Rivera, RD Alvarez, ... Gene therapy 10 (14), 1198-1204, 2003 | 74 | 2003 |
| Pro‐apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer J Xiang, J Gómez‐Navarro, W Arafat, B Liu, SD Barker, RD Alvarez, ... The Journal of Gene Medicine 2 (2), 97-106, 2000 | 64 | 2000 |
| CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses T Hakkarainen, A Hemminki, AV Pereboev, SD Barker, CK Asiedu, ... Clinical cancer research 9 (2), 619-624, 2003 | 62 | 2003 |
| Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer HA Ono, JG Davydova, Y Adachi, K Takayama, SD Barker, PN Reynolds, ... Journal of gastroenterology 40, 31-42, 2005 | 56 | 2005 |
| Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv WO Arafat, J Gomez-Navarro, DJ Buchsbaum, J Xiang, M Wang, ... Gene therapy 9 (4), 256-262, 2002 | 55 | 2002 |
| An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites SD Barker, E Casado, J Gomez-Navarro, J Xiang, W Arafat, ... Gynecologic oncology 82 (1), 57-63, 2001 | 51 | 2001 |
| Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics LV Kalman, IM Lubin, S Barker, D Du Sart, R Elles, WW Grody, M Pazzagli, ... Archives of Pathology and Laboratory Medicine 137 (7), 983-988, 2013 | 47 | 2013 |
| Development of genomic reference materials for cystic fibrosis genetic testing VM Pratt, M Caggana, C Bridges, AM Buller, L DiAntonio, WE Highsmith, ... The Journal of Molecular Diagnostics 11 (3), 186-193, 2009 | 40 | 2009 |
| Replication of an integrin targeted conditionally replicating adenovirus on primary ovarian cancer spheroids JT Lam, GJ Bauerschmitz, A Kanerva, SD Barker, JM Straughn, M Wang, ... Cancer gene therapy 10 (5), 377-387, 2003 | 39 | 2003 |
| BME labs in the era of COVID-19: Transitioning a hands-on integrative lab experience to remote instruction using gamified lab simulations TE Allen, SD Barker Biomedical Engineering Education 1 (1), 99-104, 2021 | 32 | 2021 |
| Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement P Nagi, SM Vickers, J Davydova, Y Adachi, K Takayama, S Barker, ... Journal of gastrointestinal surgery 7 (3), 364-371, 2003 | 30 | 2003 |
| Development of a genomic DNA reference material panel for Rett syndrome (MECP2-related disorders) genetic testing LV Kalman, JC Tarleton, AK Percy, S Aradhya, S Bale, SD Barker, ... The Journal of Molecular Diagnostics 16 (2), 273-279, 2014 | 15 | 2014 |
| Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing SD Barker, S Bale, J Booker, A Buller, S Das, K Friedman, AK Godwin, ... The Journal of Molecular Diagnostics 11 (6), 553-561, 2009 | 12 | 2009 |
